honokiol has been researched along with Cancer of the Thyroid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, HL; Chien, YA; Chou, HC; Chuang, HH; Lee, YR; Liao, EC; Lin, LH; Lu, CH; Su, YC; Tsai, YT; Wei, YS; Yang, YT; Yu, HI; Yu, XR | 1 |
| Chang, YS; Chen, SH; Lee, YR; Lim, YP; Liu, YW; Lu, CH; Wu, JY; Yu, HI | 1 |
2 other study(ies) available for honokiol and Cancer of the Thyroid
| Article | Year |
|---|---|
Proteomic analysis of honokiol-induced cytotoxicity in thyroid cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Survival; Cytoskeleton; Electrophoresis, Gel, Two-Dimensional; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Lignans; Magnolia; Mass Spectrometry; Neoplasm Metastasis; Plant Extracts; Protein Processing, Post-Translational; Proteome; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thyroid Neoplasms | 2018 |
Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Biphenyl Compounds; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Lignans; Signal Transduction; Thyroid Neoplasms | 2017 |